| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/02/2005 | EP1509251A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/02/2005 | EP1509238A1 Calcium-containing composition from bone tissue |
| 03/02/2005 | EP1509237A2 Methods of treating angiogenesis, tumor growth, and metastasis |
| 03/02/2005 | EP1509233A1 Liquid formulation of decitabine and use of the same |
| 03/02/2005 | EP1509188A2 Compounds active at the glucocorticoid receptor ii |
| 03/02/2005 | EP1416966A4 Methods for treating joint inflammation, pain, and loss of mobility |
| 03/02/2005 | EP1282690B9 Isolation of precursor cells and their use for tissue repair |
| 03/02/2005 | EP1244649B1 Cyclic amp-specific phosphodiesterase inhibitors |
| 03/02/2005 | EP1180018B1 Use of antiseptics in the manufacture of a pharmaceutical preparation for the prevention and treatment of infections and/ or functional tissue remodelling in the interior of the human body |
| 03/02/2005 | EP1140240B1 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 03/02/2005 | EP1129084B1 Thiazole derivatives as ppar gamma ligands |
| 03/02/2005 | EP1014976B1 Novel substituted imidazole compounds |
| 03/02/2005 | EP0991636B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/02/2005 | EP0927036B1 Transdermal therapeutical approach involving a combination of bisphosphate containing oestriol |
| 03/02/2005 | EP0871448B1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase |
| 03/02/2005 | EP0824530B1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 03/02/2005 | EP0799311B1 Human chemokine beta-9 |
| 03/02/2005 | CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function |
| 03/02/2005 | CN1589268A Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 03/02/2005 | CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/02/2005 | CN1589260A Heterocyclic compounds and methods of use thereof |
| 03/02/2005 | CN1589258A Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for their preparation and their use in the preparation of pharmaceutically important compounds |
| 03/02/2005 | CN1589145A αv整联蛋白受体拮抗剂 αv integrin receptor antagonists |
| 03/02/2005 | CN1589136A Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 03/02/2005 | CN1589134A Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof |
| 03/02/2005 | CN1586621A Injected gel type bone repairing biological active material and its preparing method |
| 03/02/2005 | CN1586609A Chinese medicine for treating bone injury disease and its preparing method |
| 03/02/2005 | CN1586608A Chinese medicine for treating traumatic injury and its preparing method |
| 03/02/2005 | CN1586600A Tibet medicine lamivphlomis root injection preparation and its preparing method |
| 03/02/2005 | CN1586590A Re-creading bolus for reinforcing kidney and generating marrow |
| 03/02/2005 | CN1586588A Medicinal composition for treatnig bone fracture |
| 03/02/2005 | CN1586559A Recovery pill for head of femur |
| 03/02/2005 | CN1586547A Medicine for treating bone wound |
| 03/02/2005 | CN1586527A Plaster for treating osteoarthropathy and preparing method |
| 03/02/2005 | CN1586513A Recipe of drynaria rhizome and dipsacus root bone setting tablet |
| 03/02/2005 | CN1586503A Recovery pill for lumbar vertebra |
| 03/02/2005 | CN1586473A Daphnetic soft capsule and its preparing method |
| 03/02/2005 | CN1191078C External use ointment for treating burn and scald |
| 03/02/2005 | CN1191070C Osteoblast-specific mitogens and drugs contining such compounds |
| 03/02/2005 | CA2479613A1 Novel adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them |
| 03/01/2005 | US6861429 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 03/01/2005 | US6861418 Modulating protein kinase signal transduction; anticancer agents |
| 03/01/2005 | US6861417 Such as 2-(4-fluorophenyl)-3-(pyridin-4-yl)pyrazine for treating cytokine mediated diseases such as psoriatic arthritis |
| 03/01/2005 | US6861409 Compounds for use in the dtreatment of growth metabolic disorders |
| 03/01/2005 | US6861406 Use of peptides or small molecules in treatment of disease, in high-throughput screening, in use of metal-binding peptides derived from sequences present in CD74-homology domain of insulin-like growth factor |
| 02/24/2005 | WO2005016928A1 Imidazopyridine derivatives |
| 02/24/2005 | WO2005016911A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | WO2005016514A2 Combinatorial synthesis on support |
| 02/24/2005 | WO2005016373A1 Osteogenesis promoter |
| 02/24/2005 | WO2005016350A1 Ammonium salts of ornithine derivatives for treating inflammatory diseases |
| 02/24/2005 | WO2004087195A3 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 02/24/2005 | WO2004009064A8 Use of neurotoxic substances for the production of a means for the treatment of joint pain and method for application of said means |
| 02/24/2005 | US20050043536 Sulfonamides |
| 02/24/2005 | US20050043516 TACI antibodies and uses thereof |
| 02/24/2005 | US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants |
| 02/24/2005 | US20050043375 Solid preparation containing single crystal form |
| 02/24/2005 | US20050043368 Osteoporosis therapy; bone disorders |
| 02/24/2005 | US20050043352 human YAK family of serine/threonine protein kinases (hyak); use treating diseases of the hematopoietic systems, including anemias, polycythemia, myelodysplastic syndrome, myelosuppression, cytopenia, male contraceptives; 2-(3-Chloro-phenylamino)-7-methoxy-quinoline-3-carboxylic acid for example |
| 02/24/2005 | US20050043350 Administering heterocyclic ether such as 5-chloro-7-hydroxy-3-(4-hydroxyphenylz)-4-oxo-1-benzopyran for prophylaxis of Alzheimer's disease, osteoporosis, cardiovascular disorders, psychological disorders, antiarthritic agents,anxiolytic agents |
| 02/24/2005 | US20050043346 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/24/2005 | US20050043344 Such as 3-(3,5-ditert-butylphenyl)-4-{3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]-1,2,4-oxadiazol-5-yl}butanoic acid; for treatment of tumor metastasis, angiogenesis, osteoporosis, arthritis, retinopathy, smooth muscle cell migration, restenosis, and atheroscelorosis |
| 02/24/2005 | US20050043340 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 02/24/2005 | US20050043335 Heterocyclic derivatives of glycinamide and their medical use |
| 02/24/2005 | US20050043333 Quinazolinone derivative |
| 02/24/2005 | US20050043330 Antiinflammation agents |
| 02/24/2005 | US20050043328 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation |
| 02/24/2005 | US20050043281 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042671 Modulation of angiogenesis |
| 02/24/2005 | US20050042667 Expression vector comprising nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of immune, hematopoietic, inflammatory and tumor diseases |
| 02/24/2005 | US20050042614 Point mutations; dipeptidyl-peptidase inhibitors; kits |
| 02/24/2005 | US20050042318 Controlling hormone sensitive diseases; solvent extraction of hops, filtration, desolventizing |
| 02/24/2005 | US20050042317 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 02/24/2005 | US20050042315 Paget's disease; antitumor agents; osteoporesis; nutrient mixture of plant extract and calcium compound |
| 02/24/2005 | US20050042312 Solubility and Absorption Promoter |
| 02/24/2005 | CA2535619A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | CA2535416A1 Imidazopyridine derivatives |
| 02/24/2005 | CA2533641A1 Lactoperoxidase as an osteogenesis promoter |
| 02/24/2005 | CA2530604A1 Combinatorial synthesis on support |
| 02/23/2005 | EP1508570A1 Novel physiolgically active substances |
| 02/23/2005 | EP1507875A2 Assay for identifying inhibitors of fc gamma riii signaling |
| 02/23/2005 | EP1507855A2 Elongase genes and uses thereof |
| 02/23/2005 | EP1507780A1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
| 02/23/2005 | EP1507779A1 Inhibitors of jak and cdk2 protein kinases |
| 02/23/2005 | EP1507775A1 Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| 02/23/2005 | EP1507773A1 Macrocyclic compounds useful as pharmaceuticals |
| 02/23/2005 | EP1507767A1 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2b and alpha-2c adrenergic receptors |
| 02/23/2005 | EP1507765A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 02/23/2005 | EP1507758A2 Indole derivatives and their use as ligands for cb2 receptors |
| 02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
| 02/23/2005 | EP1507554A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 02/23/2005 | EP1507539A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone |
| 02/23/2005 | EP1507536A2 Compositions and their uses for alleviating pain |
| 02/23/2005 | EP1507533A2 Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
| 02/23/2005 | EP1507528A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 02/23/2005 | EP1507525A1 Non-steroidal anti-androgen therapy |
| 02/23/2005 | EP1401455B1 Use of a phosphate adsorbent to treat vascular diseases |
| 02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/23/2005 | EP1313489B1 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome |